EnteroBiotix Reports Positive Phase 2a Trial Resul...
Category : Clinical Trial Update 19 March 2025EnteroBiotix Limited, a clinical-stage biopharmaceutical company focussed on developing best-in-clas...
EnteroBiotix Limited, a clinical-stage biopharmaceutical company focussed on developing best-in-clas...
High-level results from the CALYPSO phase III trial showed that eneboparatide (AZP-3601), an investi...
Opko Health, Inc., a multinational biopharmaceutical and diagnostics company, and Entera Bio Ltd., a...
Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an...
Merck, known as MSD outside of the United States and Canada, announced the presentation of positive...